How Zydus is charting the high-risk and high-reward path of drug discovery

In this edition of Pathbreakers we are joined by Zydus Lifesciences' chairman Pankaj Patel and his son and managing director of the company, Sharvil Patel. Pankaj Patel joined the business when it had an annual turnover of Rs 4 crore in 1976. Today, Zydus is among the top pharmaceutical firms in India and the US. In a wide-ranging conversation with Forbes India's Neha Bothra the father-son duo talk about Zydus' 75 year old legacy and its future roadmap. Tune in on Wednesday, January 4 at 11 am to find out how Zydus Lifesciences plans to chart the high-risk and high-reward path o
Published: Jan 4, 2023